Search 177 catalogue identities by name or alias. Find recorded vendor packages, markets and cited reference notes in one place.
15 entries have a reviewed selection of primary sources. Other entries are marked as awaiting review. A source review covers the stated claims; it does not certify a vendor, a batch, clinical efficacy or suitability for human use.
Categories such as “Healing” and “Weight Loss” are catalogue navigation labels, not evidence of an effect or an approved use. Similar names can identify different compounds; source notes flag reviewed distinctions.
Polyethylene Glycol 400 (PEG-400) is a catalogue entry whose compound-specific reference review has not yet been completed.
Pramiracetam Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Prostamax is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: bremelanotide
PT-141 is a catalogue entry whose compound-specific reference review has not yet been completed.
PT-141 / Oxytocin Nasal Spray is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
PT-141 Oral Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
PT-141 Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
PTD-DBM is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: testolone
RAD-140 is a catalogue entry whose compound-specific reference review has not yet been completed.
RAD-150 (TLB-150) is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: GLP-3R · reta
Retatrutide, also identified as LY3437943, is an investigational agonist at GIP, GLP-1 and glucagon receptors. A peer-reviewed phase 2 trial and a later sponsor-described phase 3 program are different levels of source evidence.
Retatrutide Nasal Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Retatrutide Oral Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
RU-58841 is a catalogue entry whose compound-specific reference review has not yet been completed.
RU-58841 5% / Minoxidil 10% Solution is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
S-23 is a catalogue entry whose compound-specific reference review has not yet been completed.
Selank is a catalogue entry whose compound-specific reference review has not yet been completed.
Selank Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: GLP-1S · sema
Semaglutide is a GLP-1 receptor agonist and the active substance in the EU-authorized prescription medicine Wegovy. Evidence and authorization attach to specified medicinal products and their studied use.
Semax is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: semax selank blend
Semax / Selank is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Semax / Selank / Pinealon Spray is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Semax / Selank Spray is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Semax Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: grf 1-29 · geref
Sermorelin is a catalogue entry whose compound-specific reference review has not yet been completed.
SLU-PP-332 is a catalogue entry whose compound-specific reference review has not yet been completed.
SLU-PP-332 Capsules is a catalogue entry whose compound-specific reference review has not yet been completed.
SNAP-8 is a catalogue entry whose compound-specific reference review has not yet been completed.
SNAP-8 Topical is a catalogue entry whose compound-specific reference review has not yet been completed.
Sodium Chloride 0.9% is a catalogue entry whose compound-specific reference review has not yet been completed.
SR-9009 (Stenabolic) is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: elamipretide · mtp-131
SS-31 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: bi 456906
Survodutide is a catalogue entry whose compound-specific reference review has not yet been completed.
Syn-AKE is a catalogue entry whose compound-specific reference review has not yet been completed.
Syn-Coll is a catalogue entry whose compound-specific reference review has not yet been completed.
TB-500 requires an identity check: an analytical study uses that name for an acetylated seven-amino-acid fragment, while full-length thymosin beta-4 has 43 amino acids. These are different substances.
The thymosin beta-4 17–23 fragment is a seven-amino-acid region. The TB-500 material characterized in the cited analytical paper is its N-acetylated form, acetyl-LKKTETQ.
Aliases: tesa
Tesamorelin is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: tesa ipa
Tesamorelin / Ipamorelin is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Tesamorelin Oral Spray is a catalogue entry whose compound-specific reference review has not yet been completed.